Company profile for Hummingbird Bioscience

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Hummingbird Bioscience was founded in 2015 to develop better ways of generating novel therapeutic antibody-based drugs. Using rational, systems biology approaches the aim of the company is to generate therapeutic antibodies which can be deployed in precision medicine. To further this goal the company is utilizing cutting edge single cell profiling coupled with expertise in high throughput sequencing, bioinformatics and structu...
Hummingbird Bioscience was founded in 2015 to develop better ways of generating novel therapeutic antibody-based drugs. Using rational, systems biology approaches the aim of the company is to generate therapeutic antibodies which can be deployed in precision medicine. To further this goal the company is utilizing cutting edge single cell profiling coupled with expertise in high throughput sequencing, bioinformatics and structural biology to enable our drugs to be used in the right patient at the right time.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
329 Oyster Point Boulevard South San Francisco, CA 94080
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/06/26/3105519/0/en/Hummingbird-Bioscience-Licenses-HMBD-002-Phase-II-Ready-Anti-VISTA-Monoclonal-Antibody-to-Percheron-Therapeutics.html

GLOBENEWSWIRE
25 Jun 2025

https://www.contractpharma.com/breaking-news/callio-therapeutics-launches-with-187m-series-a/

CONTRACTPHARMA
27 Feb 2025

https://www.globenewswire.com/news-release/2025/01/07/3005349/0/en/Hummingbird-Bioscience-Licenses-Novel-Antibodies-to-Immunome.html

GLOBENEWSWIRE
07 Jan 2025

https://www.globenewswire.com/news-release/2024/10/23/2967753/0/en/Hummingbird-Bioscience-Announces-Poster-Presentation-on-HMBD-802-Novel-Dual-Payload-Antibody-Drug-Conjugate-at-EORTC-NCI-AACR-2024.html

GLOBENEWSWIRE
23 Oct 2024

https://www.contractpharma.com/contents/view_breaking-news/2024-07-29/hummingbird-bioscience-appoints-new-cmo-and-coo/9769

CONTRACT PHARMA
29 Jul 2024

https://www.globenewswire.com/news-release/2024/05/13/2880181/0/en/Hummingbird-Bioscience-Presents-New-Preclinical-Data-Highlighting-Next-Generation-Antibody-Drug-Conjugate-Capabilities-at-PEGS-Boston-2024.html

GLOBENEWSWIRE
13 May 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty